Singzyme's mission is to deliver on the promise of effective immuno-therapies by developing safer and more homogenous, precision medicines for the well-being of patients worldwide. Singzyme applies its platform technology in the field of immuno-therapies with a focus on the conjugation of active molecules to protein carriers, for example, but not limited to Antibody-Drug Conjugates (ADCs). Singzyme provides an integrated, high-speed, precision bio-manufacturing platform for ADCs and other bioconjugates.